drugset / Trial / NCT02329964

Effectiveness of Sugammadex in LMS Surgery

NCT02329964

Phase 4 Unknown 80 enrolled Korea University Anam Hospital
RandomizedParallel-groupDouble-blindSupportive care

Summary

This study is comparing of rocuronium-sugammadex and succinylcholine during LMS surgery that is characterized by short operation time, required intense paralysis and ambulatory setting, has not been investigated.

Timeline

Start
2015-02
Primary completion
2015-08
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Neostigmine Other / unclassified 0.2 mg/kg
Subject Sugammadex Other / unclassified 2 mg/kg

Indications

No indication recorded.